Spago Nanomedical announces extraordinary general meeting

• Spago Nanomedical will hold an extraordinary general meeting in Stockholm on Oct. 22, 2026.
• Shareholders will vote on Employee Stock Option Program 2026/2030:A for employees, including a directed issue of up to 10,862,315 warrants.
• A separate vote will cover Employee Stock Option Program 2026/2030:B for board members, including a directed issue of up to 5,431,157 warrants.
• Both programs use a barrier set at 300% of the 5-day VWAP before the meeting, with a cap at SEK 0.80.
• Full exercise would add up to 16,293,472 shares, implying combined dilution of about 2% versus the current share count.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spago Nanomedical AB published the original content used to generate this news brief on September 21, 2026, and is solely responsible for the information contained therein.